Evidence map›Paper›PMID 30358135›Full record

ArticleArthritis care & research2019

International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group.

Martijn A H Oude Voshaar, Zofia Das Gupta, Johannes W J Bijlsma, Annelies Boonen, Jeffrey Chau, Delphine S Courvoisier, Jeffrey R Curtis, Benjamin Ellis, Sofia Ernestam, Laure Gossec and 19 more

Open access · hybridAbstract readConsensus Statement
In one paragraph

Article in Arthritis care & research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 3 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 3 syntheses or guidelines pooled it, 77 citations in OpenAlex.

  1. The use of PROMIS measures in clinical studies in patients with inflammatory arthritis: a systematic review.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 19 institutions in 13 countries.

Martijn A H Oude VoshaarUniversity of Twente, Enschede, The Netherlands.ORCID 0000-0003-2438-9973
Zofia Das GuptaInternational Consortium for Health Outcomes Measurement, London, UK.
Johannes W J BijlsmaUniversity Medical Center Utrecht, Utrecht, The Netherlands.
Annelies BoonenMaastricht University Medical Centre, Maastricht, The Netherlands.
Jeffrey ChauHong Kong Psoriatic Arthritis Association, Hong Kong, China.
Delphine S CourvoisierUniversity Hospitals of Geneva and University of Geneva, Geneva, Switzerland.
Jeffrey R CurtisUniversity of Alabama at Birmingham.ORCID 0000-0002-8907-8976
Benjamin EllisImperial College Healthcare NHS Trust, London, UK.
Sofia ErnestamKarolinska Institutet, Stockholm, Sweden.
Laure GossecSorbonne Université and Pitié Salpêtrière Hospital, AP-HP, Paris, France.
Christine HaleLockton Dunning Benefits, Dallas, Texas.
Jennifer HornjeffColumbia University Medical Centre, New York, New York.
Katy Y Y LeungSingapore General Hospital, Duke-NUS Medical School, Singapore.ORCID 0000-0001-8492-6342
Merav LidarSheba Medical Centre, Tel-Hashomer, Israel.
Phillip MeaseProvidence St. Joseph Health System, University of Washington, Seattle.
Kaleb MichaudUniversity of Nebraska Medical Center Omaha, and the National Databank for Rheumatic Diseases, Wichita, Kansas.
Girish M ModyUniversity of KwaZulu-Natal, Durban, South Africa.
Mwidimi NdosiUniversity of the West of England, Bristol, UK.
Christina H OpavaKarolinska Institutet, Stockholm, Sweden.
Geraldo R C PinheiroUniversidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Matthew SaltInternational Consortium for Health Outcomes Measurement, London, UK.
Enrique R SorianoInstituto Universitario Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
William J TaylorUniversity of Otago, Wellington, New Zealand.
Maria J H VoshaarUniversity of Twente, Enschede, The Netherlands.
Angelique E A M WeelMaasstad Hospital, Rotterdam, The Netherlands.
Maarten de WitVU University Medical Centre, Amsterdam Public Health, Amsterdam, The Netherlands.
Nico WulffraatWilhelmina Children's Hospital, Utrecht, The Netherlands.
Mart A F J van de LaarUniversity of Twente, Enschede, The Netherlands, and International Consortium for Health Outcomes Measurement, London, UK.
Harald E VonkemanUniversity of Twente, Enschede, The Netherlands, and International Consortium for Health Outcomes Measurement, London, UK.
University of Twente · NLAmsterdam UMC Location Vrije Universiteit Amsterdam · NLImperial College Healthcare NHS Trust · GBKarolinska Institutet · SEMaasstad Ziekenhuis · NLMaastricht University Medical Centre · NLOutcomes Research Consortium · USSingapore General Hospital · SGThe National Databank for Rheumatic Diseases · USUniversity of the West of England · GBColumbia University Irving Medical Center · USInstituto Universitario Hospital Italiano · ARProvidence College · USSorbonne Université · FRUniversidade do Estado do Rio de Janeiro · BRUniversity of Alabama at Birmingham · USUniversity of Geneva · CHUniversity of Otago · NZWilhelmina Children's Hospital · NL

Funding

Arthritis Research UK
6 · The paper itself

Abstract

objectiveThe implementation of value-based health care in inflammatory arthritis requires a standardized set of modifiable outcomes and risk-adjustment variables that is feasible to implement worldwide.

methodsThe International Consortium for Health Outcomes Measurement (ICHOM) assembled a multidisciplinary working group that consisted of 24 experts from 6 continents, including 6 patient representatives, to develop a standard set of outcomes for inflammatory arthritis. The process followed a structured approach, using a modified Delphi process to reach consensus on the following decision areas: conditions covered by the set, outcome domains, outcome measures, and risk-adjustment variables. Consensus in areas 2 to 4 were supported by systematic literature reviews and consultation of experts.

resultsThe ICHOM Inflammatory Arthritis Standard Set covers patients with rheumatoid arthritis (RA), axial spondyloarthritis, psoriatic arthritis, and juvenile idiopathic arthritis (JIA). We recommend that outcomes regarding pain, fatigue, activity limitations, overall physical and mental health impact, work/school/housework ability and productivity, disease activity, and serious adverse events be collected at least annually. Validated measures for patient-reported outcomes were endorsed and linked to common reporting metrics. Age, sex at birth, education level, smoking status, comorbidities, time since diagnosis, and rheumatoid factor and anti-citrullinated protein antibody lab testing for RA and JIA should be collected as risk-adjustment variables.

conclusionWe present the ICHOM inflammatory arthritis Standard Set of outcomes, which enables health care providers to implement the value-based health care framework and compare outcomes that are important to patients with inflammatory arthritis.

Indexed as

Health Status IndicatorsPatient Reported Outcome MeasuresArthritisHumansInternational CooperationOutcome Assessment, Health CareQuality of LifeRetrospective StudiesSeverity of Illness Index

Identifiers

PMID30358135
PMCPMC6900179
OpenAlexW2898114918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.